REPORT ID 388

Global Solid Tumor Drug Market Research Report 2017

Publish Date
01-Dec-17
Pages
116
Format
Electronic (PDF)

In this report, the global Solid Tumor Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Solid Tumor Drug in these regions, from 2012 to 2022 (forecast), covering
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
Global Solid Tumor Drug market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    AstraZeneca
    Biogen
    Baxter
    Celgene Corporation
    Abbott Laboratories
    Pfizer Inc
    Amgen Limited & Amgen Ireland Limited
    Bristol-Myers Squibb Company
    GlaxoSmithKline plc.
    F. Hoffmann-La Roche Ltd.
    Eli Lilly and Company
    Johnson & Johnson
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Small Molecules
    Biologics
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
    Oncology
    Neurology
    Radiology
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Solid Tumor Drug Market Research Report 2017
1 Solid Tumor Drug Market Overview
    1.1 Product Overview and Scope of Solid Tumor Drug
    1.2 Solid Tumor Drug Segment by Type (Product Category)
        1.2.1 Global Solid Tumor Drug Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
        1.2.2 Global Solid Tumor Drug Production Market Share by Type (Product Category) in 2016
        1.2.3 Small Molecules
        1.2.4 Biologics
    1.3 Global Solid Tumor Drug Segment by Application
        1.3.1 Solid Tumor Drug Consumption (Sales) Comparison by Application (2012-2022)
        1.3.2 Oncology
        1.3.3 Neurology
        1.3.4 Radiology
        1.3.5 Others
    1.4 Global Solid Tumor Drug Market by Region (2012-2022)
        1.4.1 Global Solid Tumor Drug Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
        1.4.2 North America Status and Prospect (2012-2022)
        1.4.3 Europe Status and Prospect (2012-2022)
        1.4.4 China Status and Prospect (2012-2022)
        1.4.5 Japan Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Status and Prospect (2012-2022)
        1.4.7 India Status and Prospect (2012-2022)
    1.5 Global Market Size (Value) of Solid Tumor Drug (2012-2022)
        1.5.1 Global Solid Tumor Drug Revenue Status and Outlook (2012-2022)
        1.5.2 Global Solid Tumor Drug Capacity, Production Status and Outlook (2012-2022)

2 Global Solid Tumor Drug Market Competition by Manufacturers
    2.1 Global Solid Tumor Drug Capacity, Production and Share by Manufacturers (2012-2017)
        2.1.1 Global Solid Tumor Drug Capacity and Share by Manufacturers (2012-2017)
        2.1.2 Global Solid Tumor Drug Production and Share by Manufacturers (2012-2017)
    2.2 Global Solid Tumor Drug Revenue and Share by Manufacturers (2012-2017)
    2.3 Global Solid Tumor Drug Average Price by Manufacturers (2012-2017)
    2.4 Manufacturers Solid Tumor Drug Manufacturing Base Distribution, Sales Area and Product Type
    2.5 Solid Tumor Drug Market Competitive Situation and Trends
        2.5.1 Solid Tumor Drug Market Concentration Rate
        2.5.2 Solid Tumor Drug Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global Solid Tumor Drug Capacity, Production, Revenue (Value) by Region (2012-2017)
    3.1 Global Solid Tumor Drug Capacity and Market Share by Region (2012-2017)
    3.2 Global Solid Tumor Drug Production and Market Share by Region (2012-2017)
    3.3 Global Solid Tumor Drug Revenue (Value) and Market Share by Region (2012-2017)
    3.4 Global Solid Tumor Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.5 North America Solid Tumor Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.6 Europe Solid Tumor Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.7 China Solid Tumor Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.8 Japan Solid Tumor Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.9 Southeast Asia Solid Tumor Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.10 India Solid Tumor Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Solid Tumor Drug Supply (Production), Consumption, Export, Import by Region (2012-2017)
    4.1 Global Solid Tumor Drug Consumption by Region (2012-2017)
    4.2 North America Solid Tumor Drug Production, Consumption, Export, Import (2012-2017)
    4.3 Europe Solid Tumor Drug Production, Consumption, Export, Import (2012-2017)
    4.4 China Solid Tumor Drug Production, Consumption, Export, Import (2012-2017)
    4.5 Japan Solid Tumor Drug Production, Consumption, Export, Import (2012-2017)
    4.6 Southeast Asia Solid Tumor Drug Production, Consumption, Export, Import (2012-2017)
    4.7 India Solid Tumor Drug Production, Consumption, Export, Import (2012-2017)

5 Global Solid Tumor Drug Production, Revenue (Value), Price Trend by Type
    5.1 Global Solid Tumor Drug Production and Market Share by Type (2012-2017)
    5.2 Global Solid Tumor Drug Revenue and Market Share by Type (2012-2017)
    5.3 Global Solid Tumor Drug Price by Type (2012-2017)
    5.4 Global Solid Tumor Drug Production Growth by Type (2012-2017)

6 Global Solid Tumor Drug Market Analysis by Application
    6.1 Global Solid Tumor Drug Consumption and Market Share by Application (2012-2017)
    6.2 Global Solid Tumor Drug Consumption Growth Rate by Application (2012-2017)
    6.3 Market Drivers and Opportunities
        6.3.1 Potential Applications
        6.3.2 Emerging Markets/Countries

7 Global Solid Tumor Drug Manufacturers Profiles/Analysis
    7.1 AstraZeneca
        7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.1.2 Solid Tumor Drug Product Category, Application and Specification
            7.1.2.1 Product A
            7.1.2.2 Product B
        7.1.3 AstraZeneca Solid Tumor Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.1.4 Main Business/Business Overview
    7.2 Biogen
        7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.2.2 Solid Tumor Drug Product Category, Application and Specification
            7.2.2.1 Product A
            7.2.2.2 Product B
        7.2.3 Biogen Solid Tumor Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.2.4 Main Business/Business Overview
    7.3 Baxter
        7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.3.2 Solid Tumor Drug Product Category, Application and Specification
            7.3.2.1 Product A
            7.3.2.2 Product B
        7.3.3 Baxter Solid Tumor Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.3.4 Main Business/Business Overview
    7.4 Celgene Corporation
        7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.4.2 Solid Tumor Drug Product Category, Application and Specification
            7.4.2.1 Product A
            7.4.2.2 Product B
        7.4.3 Celgene Corporation Solid Tumor Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.4.4 Main Business/Business Overview
    7.5 Abbott Laboratories
        7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.5.2 Solid Tumor Drug Product Category, Application and Specification
            7.5.2.1 Product A
            7.5.2.2 Product B
        7.5.3 Abbott Laboratories Solid Tumor Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.5.4 Main Business/Business Overview
    7.6 Pfizer Inc
        7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.6.2 Solid Tumor Drug Product Category, Application and Specification
            7.6.2.1 Product A
            7.6.2.2 Product B
        7.6.3 Pfizer Inc Solid Tumor Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.6.4 Main Business/Business Overview
    7.7 Amgen Limited & Amgen Ireland Limited
        7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.7.2 Solid Tumor Drug Product Category, Application and Specification
            7.7.2.1 Product A
            7.7.2.2 Product B
        7.7.3 Amgen Limited & Amgen Ireland Limited Solid Tumor Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.7.4 Main Business/Business Overview
    7.8 Bristol-Myers Squibb Company
        7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.8.2 Solid Tumor Drug Product Category, Application and Specification
            7.8.2.1 Product A
            7.8.2.2 Product B
        7.8.3 Bristol-Myers Squibb Company Solid Tumor Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.8.4 Main Business/Business Overview
    7.9 GlaxoSmithKline plc.
        7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.9.2 Solid Tumor Drug Product Category, Application and Specification
            7.9.2.1 Product A
            7.9.2.2 Product B
        7.9.3 GlaxoSmithKline plc. Solid Tumor Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.9.4 Main Business/Business Overview
    7.10 F. Hoffmann-La Roche Ltd.
        7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.10.2 Solid Tumor Drug Product Category, Application and Specification
            7.10.2.1 Product A
            7.10.2.2 Product B
        7.10.3 F. Hoffmann-La Roche Ltd. Solid Tumor Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.10.4 Main Business/Business Overview
    7.11 Eli Lilly and Company
    7.12 Johnson & Johnson

8 Solid Tumor Drug Manufacturing Cost Analysis
    8.1 Solid Tumor Drug Key Raw Materials Analysis
       8.1.1 Key Raw Materials
       8.1.2 Price Trend of Key Raw Materials
       8.1.3 Key Suppliers of Raw Materials
       8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
       8.2.1 Raw Materials
       8.2.2 Labor Cost
       8.2.3 Manufacturing Expenses
    8.3 Manufacturing Process Analysis of Solid Tumor Drug

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    9.1 Solid Tumor Drug Industrial Chain Analysis
    9.2 Upstream Raw Materials Sourcing
    9.3 Raw Materials Sources of Solid Tumor Drug Major Manufacturers in 2015
    9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
        10.1.1 Direct Marketing
        10.1.2 Indirect Marketing
        10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
        10.2.1 Pricing Strategy
        10.2.2 Brand Strategy
        10.2.3 Target Client
    10.3 Distributors/Traders List

11 Market Effect Factors Analysis
    11.1 Technology Progress/Risk
        11.1.1 Substitutes Threat
        11.1.2 Technology Progress in Related Industry
    11.2 Consumer Needs/Customer Preference Change
    11.3 Economic/Political Environmental Change

12 Global Solid Tumor Drug Market Forecast (2017-2022)
    12.1 Global Solid Tumor Drug Capacity, Production, Revenue Forecast (2017-2022)
        12.1.1 Global Solid Tumor Drug Capacity, Production and Growth Rate Forecast (2017-2022)
        12.1.2 Global Solid Tumor Drug Revenue and Growth Rate Forecast (2017-2022)
        12.1.3 Global Solid Tumor Drug Price and Trend Forecast (2017-2022)
    12.2 Global Solid Tumor Drug Production, Consumption , Import and Export Forecast by Region (2017-2022)
        12.2.1 North America Solid Tumor Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.2 Europe Solid Tumor Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.3 China Solid Tumor Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.4 Japan Solid Tumor Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.5 Southeast Asia Solid Tumor Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.6 India Solid Tumor Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
    12.3 Global Solid Tumor Drug Production, Revenue and Price Forecast by Type (2017-2022)
    12.4 Global Solid Tumor Drug Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology/Research Approach
        14.1.1 Research Programs/Design
        14.1.2 Market Size Estimation
        14.1.3 Market Breakdown and Data Triangulation
    14.2 Data Source
        14.2.1 Secondary Sources
        14.2.2 Primary Sources
    14.3 Disclaimer